1. , et al. Stem cell therapy in myocardial repair and remodeling. J Am Coll Surg 2008; 207(3): 423–434.
2. , et al. Model of dilated cardiomyopathy transplantation of mesenchymal stem cells improves cardiac function in a rat. Circulation 2005; 112: 1128–1135.
3. , et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107(18): 2294–2302.
4. , et al. Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. Int J Cardiol 2010; 139(2): 166–172.
5. , et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008; 135(4): 799–808.
6. , et al. Marrow stromal cells differentiate into vasculature after allogeneic transplantation into ischemic myocardium. Ann Thorac Surg 2011; 91(4): 1206–1212.
7. , et al. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. J Thorac Cardiovasc Surg 2009; 138(3): 646–653.
8. , et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing akt on cardiac metabolism after myocardial infarction. Stem Cells 2009; 27(4): 971–979.
9. , et al. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. J Cardiol 2011; 152(3): 314–320.
10. , et al. Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Comm 2009; 390(3): 902–907.
11. , et al. Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Cardiology 2009; 112: 98–106.
12. , et al. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 2007; 581: 3961–3966.
13. , . Stem cell therapy for cardiac disease. Nature 2008; 451: 937–942.
14. , et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204–1219.
15. , et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542–545.
16. , et al. Human cord blood CD34+ progenitor cells acquire functional cardiac properties through a cell fusion process. Am J Physiol Heart Circ 2011; 300(5): H1875–1884.
17. , et al. Bone-marrow derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10(5): 494–501.
18. , et al. Human mesenchymal stem cells reprogram adult cardiomyocytes towards a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells 2011; 29(5): 812–824.
19. , et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004; 229: 623–631.
20. , et al. Cardiomyocyte differentiation of rat bone marrow multipotent progenitor cells is associated with downregulation of Oct-4 expression. Tissue Eng Part A 2010; 16(10): 3111–3117.
21. , et al. VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Comm 2007; 354: 999–1003.
22. , et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002; 73: 1919–1926.
23. , , . ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117(3): 568–75.
24. , et al. STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J Mol Cell Cardiol 2007; 42 1009–1015.
25. , et al. IL-6 and TGF-alpha costimulate mesenchymal stem cell VEGF production by ERK, JNK, and PI3K-mediated mechanisms. Shock 2011; 35(5): 512–516.
26. , et al. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000; 46: 257–263.
27. , et al. Matrix elasticity directs stem cell lineage specification. Cell 2006; 126: 677–689.
28. , et al. Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments. Biotechnol Bioeng 2005; 92(4): 492–500.
29. , et al. Multiphysics simulation of left ventricular filling dynamics using fluid-structure interaction finite element method. Biophys J 2004; 87: 2074–2085.
30. , et al. Modeling Human Cardiac Fluid Mechanics. 2nd ed. Universitatsverlag Karlsruhe, Germany, 2006.
31. , et al. Characterization of the response of bone marrow-derived progenitor cells to cyclic strain: implications for vascular tissue-engineering applications. Tissue Eng 2004; 10(3/4).
32. , et al. Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol 2004; 32: 1238–1245.
33. , et al. Mechanobiology of mesenchymal stem cells and their use in cardiovascular repair. Frontiers Biosci 12 (2007), 5098–5116.
34. , et al. Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol Bioeng 2004; 88(3).
35. , et al. Mechanoelectrical excitation by fluid jets in monolayers of cultured cardiac myocytes. J Appl Physiol 2005; 98: 2328–2336.
36. , et al. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol 2005; 25: 1817–1823.
37. , . The roles of mesenchymal stem cells (MSC) therapy in ischemic heart diseases. Biochem Biophys Res Comm 359 (2007) 189–193.
38. , et al. Gene expression profiles following intracoronary injection of mesenchymal stromal cells using a porcine model of chronic myocardial infarction. Cytotherapy 2011; 13(4): 407–418.
39. , et al. Hypoxia-inducible factor 1-alpha release after intracoronary versus intramyocardial stem cell therapy in myocardial infarction. J Cardiovasc Transl Res 2010; 3(2): 114–121.
40. , et al. Myocardial flow reserve parametric map, assessed by first-pass MRI compartmental analysis at the chronic stage of infarction. J Magn Reson Imaging 2001; 13(3): 352–360.
41. , et al. Delayed recovery of myocardial blood flow after intracoronary stem cell administration. Stem Cell Rev 2011; 7(3): 616–623.
42. , et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006; 12(4): 459–465.
43. , et al. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 2007; 25: 2350–2357.
44. , et al. Enhancing a PEGylated fibrin biomatrix. Tissue Eng Part A 2008; 14(6).
45. , et al. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mat Res A 2010; 94A(4): 1100–1110.
46. , et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9(9): 1195–1201.
47. , et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. PNAS 2007; 104(5): 1643–1648.
48. , et al. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells 2008; 26: 1083–1093.
49. , et al. Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection. Biochem Cell Biol 2010; 88(4): 629–634.
50. , et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009; 27(4): 971–979.
51. , et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Molec Ther 2006; 14(6): 840–850.
52. , et al. Cardiac progenitor cell commitment is inhibited by nuclear Akt expression. Circ Res 2011; 108(8): 960–970.
53. , et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010; 107(7): 913–22.
54. , et al. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res 2011;.
55. , et al. Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. J Cell Mol Med 2011; 15(1): 63–71.
56. , et al. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res 2010; 3(5): 547–558.
57. , et al. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med 2007; 2(1): 63–68.
58. , et al. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 2011; 30(1): 95–102.
59. , et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362–1369.
60. , et al. Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation. Tissue Eng 2005; 11(11): 1780–1788.
61. , et al. Osteogenic differentiation of human mesenchymal stem cells in collagen matrices: effect of uniaxial cyclic tensile strain on bone morphogenetic protein (BMP-2) mRNA expression. Tissue Eng 2006; 12(12): 3459–3465.
62. , et al. Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 2004; 22(3): 313–323.
63. , et al. Chronotropic response of cultured neonatal rat ventricular myocytes to short-term fluid shear. Cell Biochem Biophys 2006; 46(2).
64. , et al. Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Circ Res 2011; 91(1): 99–107.
65. , et al. Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study. Cardiovasc Revasc Med 2011; 12(1): 29–34.
66. , et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54(24): 2277–2286.
67. , et al. Mechanics of ventricular torsion. JBiomech 1996; 29(6): 745–752.
68. , . Mechanics of the normal heart. J Card Surg 2006; 21: 615–620.
69. , et al. Myocardial fluid balance. Eur J Cardiothorac Surg 2001; 20: 1220–1230.
70. , et al. Transverse shear along myocardial cleavage planes provides a mechanism for normal systolic wall thickening. Circ Res 1995; 77: 182–193.
71. , et al. Changes in regional myocardial volume during the cardiac cycle: implications for transmural blood flow and cardiac structure. AJP Heart Circ Phys 2008; 295(2): H610–H618.
72. , et al. Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. Am J Physiol Heart Circ 1995; 269(38): H571–H582.
73. , et al. Direct measurement of transmural laminar architecture in the anterolateral wall of the ovine left ventricle: new implications for wall thickening mechanics. Am J Physiol Heart Circ 2005; 288: 1324–1330.
74. , et al. Relating myocardial laminar architecture to shear strain and muscle fiber orientation. Am J Physiol Heart Circ 2001; 280: H2222–H2229.
75. , et al. Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng 2007; 13(9): 2185–2193.
76. , et al. Regulation of microvascular filtration in the myocardium by interstitial fluid pressure. Am J Physiol Regulatory Integrative Comp Physiol 1996; 271: 1465–1469.
77. , et al. Intramyocardial pressure: interaction of myocardial fluid pressure and fiber stress. AJP Heart CircPhysiol 1989; 257(2): H357–H364.
78. , et al. Effects of myocardial edema on the development of myocardial interstitial fibrosis. Microcirculation 2000; 7(4): 269–280.
79. , et al. Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng 2005. 7: 223–253.
80. , et al. Left ventricular twist mechanics in a canine model of reversible congestive heart failure: a pilot study. J Am Soc Echocardio 2009; 22: 95–98.
81. , et al. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis. Am Heart J 2001; 141: 234–42.
82. , et al. Single cell mechanics of rat cardiomyocytes under isometric, unloaded, and physiologically loaded conditions. Am J Physiol Heart Circ Physiol 2004; 287: H196–H202.
83. , et al. Theoretical analysis of the adaptive contractile behaviour of a single cardiomyocyte cultured on elastic substrates with varying stiffness. J Theor Biol 2008; 255(1): 92–105.
84. , et al. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices. Cardiovasc Pathol 2011; 20(6): 325–333.
85. , et al. Mechanical stretch promotes proliferation of rat bone marrow mesenchymal stem cells. Colloids and surfaces B:Biointerfaces 2007; 58: 271–277.
86. , et al. Human mesenchymal stem cells form multicellular structures in response to applied cyclic strain. Ann Biomed Eng 2009; 37(4): 783–793.
87. , et al. The effects of GDF-5 and uniaxial strain on mesenchymal stem cells in 3-D culture. Clin Orthop Relat Res 2008; 466: 1930–1937.
88. , et al. Cyclic mechanical compression increases mineralization of cell-seeded polymer scaffolds in vivo. J Biomech Eng 2007; 129: 531–539.
89. , et al. Cyclic mechanical strain promotes transforming-growth-factor-β1-mediated cardiomyogenic marker expression in bone-marrow-derived mesenchymal stem cells in vitro. Biotech Appl Biochem 2010; 55(4): 191–197.
90. , et al. Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol 2004; 32: 1238–1245.
91. , et al. Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds. J Cell Physiol 2009; 219: 421–429.
92. , et al. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials 2006; 27: 6083–6095.
93. , et al. Response of mesenchymal stem cells to the biomechanical environment of the endothelium on a flexible tubular silicone substrate. Biomaterials 2008; 29: 1610–1619.
94. , et al. Viscoelastic behavior of human mesenchymal stem cells. BMC Cell Biol 2008; 9: 40.
95. , et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008; 26(8): 2173–2182.